Proto Labs (PRLB) Tops Q2 EPS by 7c

Proto Labs (NYSE: PRLB) reported Q2 EPS of $0.46, $0.07 better than the analyst estimate of $0.39. Revenue for the quarter came in at $126.9 million versus the consensus estimate of $127.92 million.

For earnings history and earnings-related data on Proto Labs (PRLB) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year
• Protolabs expands drone manufacturing with CNC and 3D printing